EATG » Tuberculosis

Tuberculosis

Aidspan publishes new issue of ‘Global Fund Observer’

Aidspan: Global Fund Observer Aidspan, an independent watchdog of the Global Fund to Fight AIDS, Tuberculosis and Malaria, published Issue 293 of the “Global Fund Observer.” The newsletter features articles…

Universal treatment of MDR-TB is possible within current budgets with generic production

Generic production could make novel multidrug-resistant tuberculosis (MDR-TB) regimens available for US $53–507 per treatment course according to data presented at TB2016. To read the full article, click here.

Levofloxacin: safety and tolerability in HIV positive and negative children treated for MDR-TB

Levofloxacin was safe and well tolerated in children with and without HIV in long-term use. The data provide additional support for its inclusion in paediatric TB treatment and prevention regimens.…

EMA: Development of medicines to treat TB

Comments on draft guidance invited until 31 January 2017 The European Medicines Agency (EMA) has launched a public consultation on revised guidance on the development of new medicines to treat…

Officials discuss meeting Global Fund target of US$13 billion

DURBAN, South Africa, July 26 – As the fund to help the world’s most suffering prepares for a conference hosted by Prime Minister Justin Trudeau and the government of Canada…

High-dose rifampicin for TB treatment regimen may improve survival in people with low CD4 cell counts

More aggressive TB treatment using high dose of rifampicin, in addition to ARV treatment, could reduce TB/HIV mortality among co-infected TB/HIV patients with a severe immunocompromised state, according to Corinne…

From policy to practice: How the TB-HIV response is working

A new research report from ACTION shows that while countries have taken steps in the right direction since 2014 to combat the deadly duo of TB and HIV, policy improvements…

New survey investigates levels of resistance to essential TB drugs

Geneva, 11 July 2016 – The first ever multi-country population-based survey investigating levels of the resistance to essential tuberculosis (TB) drugs was published last week in The Lancet Infectious Diseases.…

Preventable deaths of children with HIV

Reducing opportunistic infections such as TB in children with HIV could save both lives and money According to the World Health Organization (WHO), 150,000 children with HIV under 15 years…

Daily TB treatment better than intermittent

Cutting back on standard regimens leads to more failures DURBAN, South Africa, July 21 – Patients diagnosed with tuberculosis as well as HIV do better in combating tuberculosis with an…